Navigation Links
Gene in Melanomas

Research in mice has drawn a direct link between a human gene and the risk of melanoma, the deadliest form of skin cancer.A team led by Professor Marco Polo from the National Centre of Investigative Oncology in Sweden found that genetically engineered mice with a mutation in the gene, known as Cdk4, were more likely to develop melanomas when exposed to cancer-causing agents. Their results appear in the latest issue of the Proceedings of the National Academy of Cancers.//

Seventy four per cent of the Cdk4 mutant mice developed melanomas after being exposed to carcinogenic treatment, the authors report.The finding gives a better understanding of the body processes underlying melanoma, which could eventually lead to better treatments.

The Cdk4 gene has been known to be more common in people with melanomas, but this is the first time it has been established as a definite risk factor.The gene codes for the Cdk4 protein, a molecule that promotes cell growth and proliferation. Melanomas, like all cancers, are caused by the unregulated growth of cells that spread via the blood to other organs in the body.

The specific mutation in the Cdk4 gene renders the Cdk4 protein insensitive to a family of regulatory molecules that normally play a role in switching it off, known as INK4 proteins. The INK4 proteins usually have a 'double-negative' effect, blocking Cdk4's neutralising effect on another growth-suppressing protein. When INK4 proteins are disabled, cell growth continues unchecked.

The study of mice carrying the Cdk4 mutation will improve understanding of the complex series of events leading to the development and progression of melanomas.This knowledge, in turn, will allow the development of vaccines and other new anti-cancer drugs.


'"/>




Page: 1

Related medicine news :

1. Latest device for identifying Melanomas
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene Melanomas

(Date:10/10/2008)...D, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Hologi...ufacturer and supplier of premium,diagnostics, med...ed to,serving the healthcare needs of women, today... fiscal 2008 operating results on Tuesday, Novembe... the release, management will,host a conference ca...
(Date:10/10/2008)... Topics range from bullying to inco... Boston (Vocus) October 10, 2008 -- Several ped...enter will be presenting at the 2008 American Aca...ion, which runs from October 11 - 14 in Boston. Pr...rician Dana Best, MD, MPH, will present "Prom...
(Date:10/10/2008)...AN CAPISTRANO, Calif., Oct. 10 /PRNewswire/ -- A s... Utah,s Uinta Mountains in a small,plane. The high...pilot Roy,Heden. The thrill came from a last-wish ...of Silverado Senior Living, where Heden was a pati...k of cards and it has helped,many realize a specia...
(Date:10/10/2008)...ests poor self-care partly to blame , , ...Medicare beneficiaries who have diabetes, being de...ccording to a new study. , Publishing in the ...Medicine , researchers from the University of Wash...age age of 75.6 years) who had diabetes and were e...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Older Diabetics With Depression Face Higher Death Rate 2
Asthma can Be Checked, Experts are Confident
...may be a life saver for today’s urban woman, who t... to swig drinks at social gatherings or home,// al...orn. That breast cancer is linked to alcohol cons...cent studies have shown that 60 percent of breast ...
...tients suffering dementia lead a troubled existenc...er if they lead uninteresting lives. An// estimate... and most of them live in solitary confinement. Th... lack of mental stimulation, social activity and a...
... the US are ringing alarm bells over a looming sho...s arising at a time of continued outbreaks among//... risking the nation's food supply, they warn. At ...ry Medical Association estimates the shortage at a...
Other Medicine News:Health News:Asthma can Be Checked, Experts are Confident 2Health News:Asthma can Be Checked, Experts are Confident 3Health News:Asthma can Be Checked, Experts are Confident 4Health News:Drinks and Breast Cancer – How It Happen 2Health News:Drinks and Breast Cancer – How It Happen 3Health News:Dementia – Worse With a Dull Life. Keep Busy, and Active to Improve Memory, Study Recommend 2Health News:Shortage of Veterinarians Worry Public Health Experts in US 2Health News:Shortage of Veterinarians Worry Public Health Experts in US 3
(Date:10/10/2008)... Calif., Oct. 10 /-,XTENT, ...s to present,long-term follow-up data from the CUS... Cardiovascular Research Foundation,s (CRF) twenti...cs (TCT) meeting in Washington, DC.,The CUSTOM cli...nvestigate,the safety and efficacy of the Custom N...
(Date:10/10/2008)...xis Treatment with Kogenate FS Reduces the,Risk of... No Pre-Existing,Joint Damage, BERKELEY, Calif., ...nced today that the U.S. Food and Drug Administrat...genate(R) FS Antihemophilic Factor,(Recombinant) t...e risk of,joint damage in patients aged 0-16 years...
(Date:10/10/2008)...Newswire-FirstCall/ -- Boston Scientific,Corporati...he Company,s major,events and press announcements ...twentieth annual Transcatheter Cardiovascular Ther...om October 12 to 17 in Washington, D.C., Boston S...y and,efficacy data on its TAXUS(R) Express2(TM) a...
(Date:10/9/2008)... Spread Awareness and Bring Hope to Millions,of Ch...Newswire/ -- 133 million children,across the globe...atural,disaster, civil war, and disease. SOS Child...phan Week by calling attention to the needs of orp...ase, go to:, http://www.prnewswire.com/mnr/sosch...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2CCMR gets 242 9M for training grad students in nanoscale science 744 1CCMR gets 242 9M for training grad students in nanoscale science 744 2Smart insulin nanostructures pass feasibility test UT study reports 740 1Smart insulin nanostructures pass feasibility test UT study reports 740 2Friends of Mel Announce Recall of Jewelry Due to Lead 1755 1Friends of Mel Announce Recall of Jewelry Due to Lead 1755 2Friends of Mel Announce Recall of Jewelry Due to Lead 1755 3ABC TV San Francisco Features Canine Cancer Research Story 3A Saving Our Dogs Helping Humans Beat Cancer Work at Morris Animal Foundation UC Davis 1751 1ABC TV San Francisco Features Canine Cancer Research Story 3A Saving Our Dogs Helping Humans Beat Cancer Work at Morris Animal Foundation UC Davis 1751 2
...NOVIVE Pharmaceuticals,Inc. (OTCBB: IVPH) today a... INNO-406, an orally bioavailable dual Bcr-Abl and...treatment-intolerant chronic myelogenous leukemia,... Clinical Oncology Annual,Meeting. The meeting tak...cago, Illinois., Information related to the presen...
.../ -- Vical,Incorporated today announced that a mea...fectin(TM) adjuvant elicited protective,levels of ...d),nonhuman primates confirmed by complete protect...accination, and sterilizing,immunity as evidenced ...virus after challenge. In a separate study, the sa...
Other Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4
Ascent Anterior Referencing Femoral Instrument Case
The Lineage acetabular system with metal liners uses sophisticated manufacturing methods and materials to minimize wear debris generation.
The Pivot Bipolar was designed with a simple one-step assembly interface between the femoral head and the compression molded liner which requires no instruments and reduces OR time.
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene.
Medicine Products: